Portage Biotech Stock Forward View
| PRTGDelisted Stock | USD 6.08 0.54 9.75% |
Portage Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Portage Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 20th of February 2026, The value of RSI of Portage Biotech's share price is at 53 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Portage Biotech, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
Using Portage Biotech hype-based prediction, you can estimate the value of Portage Biotech from the perspective of Portage Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Portage Biotech on the next trading day is expected to be 4.44 with a mean absolute deviation of 0.50 and the sum of the absolute errors of 30.79. Portage Biotech after-hype prediction price | USD 6.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Portage |
Portage Biotech Additional Predictive Modules
Most predictive techniques to examine Portage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Portage using various technical indicators. When you analyze Portage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Portage Biotech Naive Prediction Price Forecast For the 21st of February
Given 90 days horizon, the Naive Prediction forecasted value of Portage Biotech on the next trading day is expected to be 4.44 with a mean absolute deviation of 0.50, mean absolute percentage error of 0.43, and the sum of the absolute errors of 30.79.Please note that although there have been many attempts to predict Portage Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Portage Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Portage Biotech Stock Forecast Pattern
| Backtest Portage Biotech | Portage Biotech Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Portage Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Portage Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.2741 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.5048 |
| MAPE | Mean absolute percentage error | 0.077 |
| SAE | Sum of the absolute errors | 30.7915 |
Predictive Modules for Portage Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Portage Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Portage Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Portage Biotech After-Hype Price Density Analysis
As far as predicting the price of Portage Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Portage Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Portage Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Portage Biotech Estimiated After-Hype Price Volatility
In the context of predicting Portage Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Portage Biotech's historical news coverage. Portage Biotech's after-hype downside and upside margins for the prediction period are 6.08 and 6.08, respectively. We have considered Portage Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Portage Biotech is very steady at this time. Analysis and calculation of next after-hype price of Portage Biotech is based on 3 months time horizon.
Portage Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Portage Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Portage Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Portage Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 6 Events / Month | 2 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
6.08 | 6.08 | 0.00 |
|
Portage Biotech Hype Timeline
Portage Biotech is at this time traded for 6.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Portage is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Portage Biotech is about 0.0%, with the expected price after the next announcement by competition of 6.08. About 61.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 5.72. Portage Biotech last dividend was issued on the 4th of June 2020. The entity had 1:20 split on the 15th of August 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.Portage Biotech Related Hype Analysis
Having access to credible news sources related to Portage Biotech's direct competition is more important than ever and may enhance your ability to predict Portage Biotech's future price movements. Getting to know how Portage Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Portage Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KA | Kineta Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMNN | Imunon Inc | (0.05) | 7 per month | 0.00 | (0.09) | 6.74 | (5.45) | 21.83 | |
| PIRS | Pieris Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CYAD | Celyad SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WENA | Anew Medical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TOVX | Theriva Biologics | (3.88) | 9 per month | 0.00 | (0.04) | 10.53 | (13.64) | 38.10 | |
| REUN | Reunion Neuroscience | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CSCI | COSCIENS Biopharma | 0.1 | 9 per month | 10.83 | 0.01 | 27.11 | (28.04) | 94.83 | |
| NTBL | Notable Labs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SQZB | SQZ Biotechnologies | 0.00 | 0 per month | 0.00 | 0.01 | 0.00 | 0.00 | 50.43 |
Portage Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Portage Biotech stock to make a market-neutral strategy. Peer analysis of Portage Biotech could also be used in its relative valuation, which is a method of valuing Portage Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Portage Biotech Market Strength Events
Market strength indicators help investors to evaluate how Portage Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Portage Biotech shares will generate the highest return on investment. By undertsting and applying Portage Biotech stock market strength indicators, traders can identify Portage Biotech entry and exit signals to maximize returns.
Portage Biotech Risk Indicators
The analysis of Portage Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Portage Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting portage stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.06 | |||
| Standard Deviation | 7.31 | |||
| Variance | 53.51 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Portage Biotech
The number of cover stories for Portage Biotech depends on current market conditions and Portage Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Portage Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Portage Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Portage Stock
If you are still planning to invest in Portage Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Portage Biotech's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |